EC Clinical and Medical Case Reports

Case Study Volume 6 Issue 7 - 2023

Role of PET-CT in POEMS Syndrome - Case Study (AFIRI-MH)

Nayab Mustansar*

MS (Nuclear Medicine) Registrar Radiology-AFIRI, Pakistan

*Corresponding Author: Nayab Mustansar, MS (Nuclear Medicine) Registrar Radiology-AFIRI, Pakistan.
Received: April 14, 2023; Published: June 29, 2023

POEMS syndrome is a lymphoproliferative disease, a paraneoplastic disorder. POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes). Moreover its other important traits include sclerotic bone lesions, thrombocytosis, pappilloedema, clubbing, castlemans disease [1]. The radiological findings of bone lesions differ from those in myeloma in the sclerotic appearance of focal lesions [2,4]. In the majority of patients the diagnosis is confirmed by the identification of monoclonal plasma cells obtained through biopsy of an osteosclerotic lesion; as such, a whole-body X-ray survey is essential to detect focal lesions [5-7].

Keywords: POEMS Syndrome; POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, M-Protein and Skin Changes); PET-CT

  1. Dispenzieri A and Buadi FK. “A review of POEMS syndrome”. Oncology 27 (2013): 1242-1250.
  2. Minarik J., et al. “Comparison of imaging methods in POEMS syndrome”. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic 156 (2012): 52-57.
  3. Glazebrook K., et al. “Computed tomography assessment of bone lesions in patients with POEMS syndrome”. European Radiology 25 (2015): 497-504.
  4. Chong ST., et al. “POEMS syndrome: radiographic appearance with MRI correlation”. Skeletal Radiology 35 (2006): 690-695.
  5. Albertí MA., et al. “18F-FDG PET/CT in the evaluation of POEMS syndrome”. European Journal of Radiology 76 (2010): 180-182.
  6. Montoriol PF., et al. “Two more cases of evaluation of POEMS syndrome using 18FDG PET/CT”. European Journal of Radiology 80 (2011): 861-864.
  7. Fonti R., et al. “Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma”. The Journal of Nuclear Medicine 53 (2012): 1829-1835.
  8. Gallicchio R., et al. “F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma”. European Journal of Haematology 92 (2014): 382-389.
  9. Park S., et al. “Positive correlation between baseline PET or PET/CT findings and clinical parameters in multiple myeloma patients”. Acta Haematologica 131 (2014): 193-199.
  10. Esfahani SA., et al. “Baseline total lesion glycolysis measured with 18F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot study”. American Journal of Nuclear Medicine and Molecular Imaging 3 (2013): 272-281.
  11. Dispenzieri A. “POEMS syndrome”. Blood Reviews 21 (2007): 285-299.
  12. Walker RC., et al. “Imaging of multiple myeloma and related plasma cell dyscrasias”. The Journal of Nuclear Medicine 53 (2012): 1091-1101.
  13. Cui RT., et al. “POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes) syndrome in China”. Internal Medicine Journal 41 (2011): 481-485.
  14. Zhang B., et al. “The clinical study of POEMS syndrome in China”. Neuroendocrinology Letters 31 (2010): 229-237.
  15. Zhu W-G., et al. “A clinical analysis of 32 cases of POEMS syndrome”. Zhonghua Nei Ke Za Zhi 45 (2006): 108-111.
  16. Shibuya K., et al. “Detection of bone lesions by CT in POEMS syndrome”. Internal Medicine 50 (2011): 1393-1396.

Nayab Mustansar. "Role of PET-CT in POEMS Syndrome - Case Study (AFIRI-MH)." EC Clinical and Medical Case Reports   6.7 (2023): 37-39.